Therapeutic agents for the treatment of multiple drug resistance of cancers
AssigneeDebiopharm S.A.
InventorsBruno Chauffert, Philippe Genne, Gilles Gutierrez, Rolland-Yves Mauvernay
Life of this patent
Estimating the term…
Abstract
Cinchonine, dihydrocinchonine or hydroquinidine are used as multidrug resistance inhibiting substance in the treatment of cancerous tumors by the use of cytotoxic agents. Particularly, cinchonine, dihydrocinchonine or hydroquinidine are used in the preparation of pharmaceutical compositions used in the treatment of cancerous tumors developing the phenomenon of multidrug resistance. Application to the treatment of human cancers.
Claims5
A method for treating a patient suffering from multiple drug resistance, which comprises administering to said patient a compound comprising cinchonine and/or hydroquinidine in an amount effective to inhibit the multiple drug resistance of said patient.
Dependencies are inferred from the claim text.